| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-152 | Cisplatin | ovarian cancer | Resistant | High | 19074899 | |
| miR-15b | Cisplatin | tongue cancer | Sensitive | Low | 21725369 | |
| miR-15a | Cisplatin | ovarian cancer | Resistant | High | 22614869 | |
| miR-15b | Cisplatin | ovarian cancer | Resistant | High | 22614869 | |
| miR-15b | Cisplatin | cervical cancer | Associated | Low | 22920753 | |
| miR-15 | Cisplatin | epidermoid carcinoma, | Sensitive | Low | 22942255 | |
| miR-155 | Cisplatin | epidermoid carcinoma, | Sensitive | Low | 22942255 | |
| miR-155 | Cisplatin | lung cancer | Resistant | Low | 22996741 | |
| miR-155 | Cisplatin | colon cancer | Resistant | Low | 23036199 | |
| miR-155 | Cisplatin | caski cervical cancer | Sensitive | Low | 23284982 | |
| miR-152 | Cisplatin | ovarian cancer | Sensitive | Low | 23318422 | |
| miR-150 | Cisplatin | ovarian cancer | Resistant | Low | 23554878 | |
| miR-155* | Cisplatin | lung adenocarcinoma | Sensitive | High | 23700794 | |
| miR-155 | Cisplatin | squamous cell carcinoma | Resistant | High | 23831023 | |
| miR-153 | Cisplatin | colorectal cancer | Resistant | Low | 23950211 | |
| miR-150 | Cisplatin | bladder cancer | Resistant | Low | 25287716 | |
| miR-15a | Cisplatin | breast cancer | Sensitive | High | 25394901 | |
| miR-155 | Cisplatin | neuroblastoma | Resistant | Low | 25972604 | |
| miR-155 | Cisplatin | ovarian cancer | Sensitive | High | 26043084 |